← Back to Search

Supportive + Cognitive Behavioural Therapy for High Risk of Psychosis

N/A
Recruiting
Led By Jean M Addington, PhD
Research Sponsored by University of Calgary
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be younger than 65 years old
Must not have
IQ less than 70
past or current history of a clinically significant central nervous system disorder
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline and 18 months
Awards & highlights
No Placebo-Only Group

Summary

This trial will be testing whether different psychological interventions can prevent young people at risk for psychosis from developing the condition.

Who is the study for?
This trial is for young people who are at high risk of developing psychosis but haven't yet. They should not have had a psychotic disorder before, an IQ below 70, or significant brain-related health issues.
What is being tested?
The study tests stepped care in youth at risk for psychosis. It starts with supportive therapy and can step up to intensive Cognitive Behavioral Therapy (CBT) if needed, with progress checks every 6 months.
What are the potential side effects?
While the trial doesn't involve medication, psychological interventions like CBT may cause temporary discomfort such as increased anxiety or self-awareness during early treatment stages.

Eligibility Criteria

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:
Select...
My IQ is below 70.
Select...
I have a history of a serious brain or nerve disorder.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline and 18 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline and 18 months for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Scale of Psychosis Risk Symptoms
Secondary study objectives
Global Functioning Scale: Social and Role

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups
Experimental Treatment
Group I: Open treatmentExperimental Treatment1 Intervention
Supportive therapy followed by CBT

Find a Location

Who is running the clinical trial?

University of CalgaryLead Sponsor
811 Previous Clinical Trials
892,755 Total Patients Enrolled
2 Trials studying Schizophrenia
115 Patients Enrolled for Schizophrenia
Jean M Addington, PhDPrincipal InvestigatorUniversity of Calgary
1 Previous Clinical Trials
203 Total Patients Enrolled

Media Library

Supportive therapy Clinical Trial Eligibility Overview. Trial Name: NCT04829292 — N/A
Schizophrenia Research Study Groups: Open treatment
Schizophrenia Clinical Trial 2023: Supportive therapy Highlights & Side Effects. Trial Name: NCT04829292 — N/A
Supportive therapy 2023 Treatment Timeline for Medical Study. Trial Name: NCT04829292 — N/A
~17 spots leftby Apr 2026
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top